ERNA — Ernexa Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Brooklyn Immunotherapeutics - On Jan 3, 2022, Co Completed Reduction In Force Comprising Eight Employees (53% Of Workforce)
Brief: Brooklyn Immunotherapeutics Added To Ice Biotechnology Index
Brief: Brooklyn Immunotherapeutics Named To Nasdaq Biotechnology Index
Brief: Brooklyn Immunotherapeutics Welcomes Susan Mcclatchey As Vice President And Head Of Quality
Brief: Brooklyn Immunotherapeutics Announces Filing Of Registration Statement For Proposed Secondary Offering Of Shares
Brief: Brooklyn Immunotherapeutics Posts Quarterly Loss Per Share Of $1.70